Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 10, 2012, Pages 1459-1466

  Ye, Juan ^a   Zhang, Huina ^a   Wu, Han ^a   Wang, Changjun ^a   Shi, Xin ^a   Xie, Jiajun ^a   He, Jinjing ^a   Yang, Jun ^b,c  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

H2AX foci; Chang conjunctival cells; Cytoprotective; DNA damage; Hyaluronic acid; Hydroxypropyl methylcellulose; ROS; Thimerosal

Indexed keywords

HISTONE H2AX; HYALURONIC ACID; HYDROXYMETHYLCELLULOSE; REACTIVE OXYGEN METABOLITE; THIOMERSAL;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; DRUG DETERMINATION; DRUG EFFECT; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SINGLE STRANDED DNA BREAK;

CELL LINE; CELL SURVIVAL; COMET ASSAY; CONJUNCTIVA; CYTOPROTECTION; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; HYALURONIC ACID; METHYLCELLULOSE; MICROSCOPY, FLUORESCENCE; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL; REACTIVE OXYGEN SPECIES; THIMEROSAL; VISCOSUPPLEMENTS;

EID: 84867745383     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-2087-4     Document Type: Article

References (48)

1. Van Horn DL, Edelhauser HF, Prodanovich G, Eiferman R, Pederson HF (1977) Effect of the ophthalmic preservative thimerosal on rabbit and human corneal endothelium. Invest Ophthalmol Vis Sci 16:273-280
2. Mondino BJ, Groden LR (1980) Conjunctival hyperemia and corneal infiltrates with chemically disinfected soft contact lenses. Arch Ophthalmol 98:1767-1770
3. Ferrat L, Romeo M, Gnassia-Barelli M, Pergent-Martini C (2002) Effects of mercury on antioxidant mechanisms in the marine phanerogam Posidonia oceanica. Dis Aquat Organ 50:157-160
4. Ben-Ozer EY, Rosenspire AJ, McCabe MJ Jr, Worth RG, Kindzelskii AL, Warra NS, Petty HR (2000) Mercuric chloride damages cellular DNA by a non-apoptotic mechanism. Mutat Res 470:19-27
5. Morgan SE, Kastan MB (1997) p53 and ATM: cell cycle, cell death, and cancer. Adv Cancer Res 71:1-25
6. Moll UM, Slade N (2004) p63 and p73: roles in development and tumor formation. Mol Cancer Res 2:371-386
7. Aragona P, Di SG, Ferreri F, Spinella R, Stilo A (2002) Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjogren's syndrome patients. Br J Ophthalmol 86:879-884
8. Aragona P, Papa V, Micali A, Santocono M, Milazzo G (2002) Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 86:181-184
9. Johnson ME, Murphy PJ, Boulton M (2006) Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefes Arch Clin Exp Ophthalmol 244:109-112
10. Toda I, Shinozaki N, Tsubota K (1996) Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjogren's syndrome. Cornea 15:120-128
11. Urtti A (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 58:1131-1135
12. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels ofDNAdamage in individual cells. Exp Cell Res 175:184-191
13. Zhou C, Li Z, Diao H, Yu Y, Zhu W, Dai Y, Chen FF, Yang J (2006) DNA damage evaluated by gammaH2AX foci formation by a selective group of chemical/physical stressors. Mutat Res 604:8-18
14. Sasaki H, Igarashi Y, Nagano T, Nishida K, Nakamura J (1995) Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers. Pharm Res 12:1146-1150
15. Kumaravel TS, Jha AN (2006) Reliable Comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals. Mutat Res 605:7-16
16. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W (2002) Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 12:162-169
17. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A (2004) H2AX: the histone guardian of the genome. DNA Repair (Amst) 3:959-967
18. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM (2002) Quantitative detection of (125)IdU-induced DNA doublestrand breaks with gamma-H2AX antibody. Radiat Res 158:486-492
19. Schein OD, Hibberd PL, Starck T, Baker AS, Kenyon KR (1992) Microbial contamination of in-use ocular medications. Arch Ophthalmol 110:82-85
20. Fuerst DJ, Sugar J, Worobec S (1983) Superior limbic keratoconjunctivitis associated with cosmetic soft contact lens wear. Arch Ophthalmol 101:1214-1216
21. Whittington CV (1985) Elicitation of contact lens allergy to thimerosal by eye cream. Contact Dermatitis 13:186
22. Zadnik K (1984) Severe allergic reaction to saline preserved with thimerosal. J Am Optom Assoc 55:507-509
23. Coward BD, Neumann R, Callender M(1984) Solution intolerance among users of four chemical soft lens care regimens. Am J Optom Physiol Opt 61:523-527
24. Mondino BJ, Brawman-Mintzer O, Boothe WA (1987) Immunological complications of soft contact lenses. J Am Optom Assoc 58: 832-835
25. Wilson LA, McNatt J, Reitschel R (1981) Delayed hypersensitivity to thimerosal in soft contact lens wearers. Ophthalmology 88:804-809
26. Shulman IA, Hasz LA, Simpson RB (1982) Thimerosal dependent agglutination, a newly described blood bank problem. Transfusion 22:241-243
27. Shulman IA, Simpson RB, Farmer CF, Lam HT (1984) Thimerosal-dependent agglutination complicating the serologic evaluation for unexpected antibodies. Transfusion 24:365-367
28. Shenker BJ, Guo TL, O I, Shapiro IM (1999) Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol Appl Pharmacol 157:23-35
29. Ariza ME, Holliday J, Williams MV (1994) Mutagenic effect of mercury (II) in eukaryotic cells. In Vivo 8:559-563
30. Hamilton-Koch W, Snyder RD, Lavelle JM (1986) Metal-induced DNA damage and repair in human diploid fibroblasts and Chinese hamster ovary cells. Chem Biol Interact 59:17-28
31. McKelvey-Martin VJ, Green MH, Schmezer P, Pool-Zobel BL, De Meo MP, Collins A (1993) The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 288:47-63
32. Fernandez-Capetillo O, Celeste A, Nussenzweig A (2003) Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell Cycle 2:426-427
33. Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC, Naka K, Xia Z, Camerini-Otero RD, Motoyama N, Carpenter PB, Bonner WM, Chen J, Nussenzweig A (2002) DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol 4:993-997
34. Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD (2004) Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 52:794-804
35. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195-1214
36. Clarkson TW, Magos L (2006) The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36:609-662
37. Migdal C, Foggia L, Tailhardat M, Courtellemont P, Haftek M, SerresM(2010) Sensitization effect of thimerosal ismediated in vitro via reactive oxygen species and calcium signaling. Toxicology 274:1-9
38. Barzilai A, Yamamoto K (2004) DNA damage responses to oxidative stress. DNA Repair (Amst) 3:1109-1115
39. Pisella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C (2000) Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res 32:3-8
40. Kim SW, Bae YH, Okano T (1992) Hydrogels: swelling, drug loading, and release. Pharm Res 9:283-290
41. Leibowitz HM, Chang RK, Mandell AI (1984) Gel tears. A new medication for the treatment of dry eyes. Ophthalmology 91:1199-1204
42. Pape LG, Balazs EA (1980) The use of sodium hyaluronate (Healon) in human anterior segment surgery. Ophthalmology 87:699-705
43. DeLuise VP, Peterson WS (1984) The use of topical Healon tears in the management of refractory dry-eye syndrome. Ann Ophthalmol 16:823-824
44. Stuart JC, Linn JG (1985) Dilute sodium hyaluronate (Healon) in the treatment of ocular surface disorders. Ann Ophthalmol 17:190-192
45. Gill GW, Frost JK, Miller KA (1974) A new formula for a halfoxidized hematoxylin solution that neither overstains nor requires differentiation. Acta Cytol 18:300-311
46. Papa V, Aragona P, Russo S, Di BA, Russo P, Milazzo G (2001) Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients. Ophthalmologica 215:124-127
47. Pauloin T, Dutot M, Warnet JM, Rat P (2008) In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride. Eur J Pharm Sci 34:263-273
48. Augustin AJ, Dick HB (2004) Oxidative tissue damage after phacoemulsification: influence of ophthalmic viscosurgical devices. J Cataract Refract Surg 30:424-427